BIB stock icon

ProShares Ultra NASDAQ Biotechnology

58.97 USD
-2.78
4.50%
At close Nov 14, 4:00 PM EST
1 day
-4.50%
5 days
-9.56%
1 month
-7.73%
3 months
-5.41%
6 months
4.71%
Year to date
-0.59%
1 year
35.19%
5 years
14.71%
10 years
3.13%
0
Funds holding %
of 6,759 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

40% more capital invested

Capital invested by funds: $4.63M [Q1] → $6.5M (+$1.87M) [Q2]

14% more funds holding

Funds holding: 21 [Q1] → 24 (+3) [Q2]

2.08% more ownership

Funds ownership: 4.79% [Q1] → 6.87% (+2.08%) [Q2]

21% less call options, than puts

Call options by funds: $764K | Put options by funds: $972K

40% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 5

Research analyst outlook

We haven’t received any recent analyst ratings for BIB.

Financial journalist opinion

Charts implemented using Lightweight Charts™